Protocol for initiation of miglustat treatment in NP-C. Reproduced

Protocol for initiation of miglustat treatment in NP-C. Reproduced with

Substrate reduction therapy in the infantile form of Tay-Sachs disease

Protocol for initiation of miglustat treatment in NP-C. Reproduced with

Protocol for initiation of miglustat treatment in NP-C. Reproduced with

Distinct Niemann-Pick Disease Type C Clinical, Cytological, and Biochemical Phenotype in an Adult Patient With 1 Mutated, Overexpressed NPC1 Allele - Julia Jecel, Klaus Harzer, Eduard Paschke, Stefanie Beck-Wödl, Peter Bauer, Milos

IJMS, Free Full-Text

SEC Filing Orphazyme A/S

Frontiers Adult-Onset Niemann–Pick Disease Type C: Rapid Treatment Initiation Advised but Early Diagnosis Remains Difficult

Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression

Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice: Molecular Therapy

Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice

Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease

Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression